Literature DB >> 3188849

Visual analogue scale assessment of postoperative swelling. A study of clinical inflammatory variables subsequent to third-molar surgery.

T I Berge1.   

Abstract

Subsequent to removal of impacted lower third molars the interrelationship of four postoperative variables (swelling, pain, trismus, and dysphagia) was assessed. Patient assessment of postoperative swelling using a visual analogue scale (VAS) was easily accepted by a group (n = 40) of patients aged 17 to 46 years. A significantly positive correlation (r = 0.66, p less than 0.01) existed between metric extraoral swelling and VAS-assessed swelling; however, the latter may represent a more sensitive method when swelling is discrete. Both extraorally and VAS-assessed swelling showed no correlation with dysphagia and VAS-assessed pain. Trismus correlated moderately positively with pain and extraoral swelling (r = 0.38, p less than 0.05) and dysphagia (p less than 0.01). In the present study dysphagia showed no correlation with pain. This study shows that registration of postoperative swelling by means of a VAS may be a sensitive and accurate method with obvious practical advantages.

Entities:  

Mesh:

Year:  1988        PMID: 3188849     DOI: 10.3109/00016358809004772

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  11 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1989 May-Jun

2.  To compare standard incision and comma shaped incision and its influence on post-operative complications in surgical removal of impacted third molars.

Authors:  Saravana Kumar B; Sarumathi T; Veerabahu M; Uma Raman
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Comparative Evaluation of Immediate Post-Operative Sequelae after Surgical Removal of Impacted Mandibular Third Molar with or without Tube Drain - Split-Mouth Study.

Authors:  Barun Kumar; Kalyani Bhate; R S Dolas; Sn Santhosh Kumar; Pushkar Waknis
Journal:  J Clin Diagn Res       Date:  2016-12-01

4.  Is post-operative antibiotic therapy justified for surgical removal of mandibular third molar? A comparative study.

Authors:  Vikrant Dilip Sane; Kiran Shrikrishna Gadre; Sanjay Chandan; Rajshekhar Halli; Rashmi Saddiwal; Pankaj Kadam
Journal:  J Maxillofac Oral Surg       Date:  2013-04-06

5.  Benefits of not Prescribing Prophylactic Antibiotics After Third Molar Surgery.

Authors:  Anchal Prajapati; Aalap Prajapati; Swati Sathaye
Journal:  J Maxillofac Oral Surg       Date:  2015-07-05

6.  Primary and secondary closure of the surgical wound after removal of impacted mandibular third molars.

Authors:  Kiran Khande; Harish Saluja; Uma Mahindra
Journal:  J Maxillofac Oral Surg       Date:  2011-04-22

7.  The efficacy of intralesional dexamethasone versus intravenous dexamethasone in surgery for impacted third molars: A randomized controlled trial.

Authors:  Amiya Agrawal; Siddhartha Chandel; Nishi Singh; Arunesh Kumar Tiwari; Akhilesh Kumar Singh; Gaurav Singh
Journal:  Natl J Maxillofac Surg       Date:  2020-06-18

8.  Efficacy of single dose azithromycin as prophylactic antibiotic in surgical removal of mandibular third molars: a clinical study.

Authors:  Vikrant Dilip Sane; Kiran Shrikrishna Gadre; Sanjay Chandan; Shandilya Ramanojam; Vikram Singh; Rajshekhar Halli
Journal:  J Maxillofac Oral Surg       Date:  2013-01-11

9.  Primary and secondary closure technique following removal of impacted mandibular third molars: A comparative study.

Authors:  Manoj Chaudhary; Manpreet Singh; Sanjay Singh; S P Singh; Gagandeep Kaur
Journal:  Natl J Maxillofac Surg       Date:  2012-01

10.  Efficacy of Submucosal Injection of Chymotrypsin, Oral Serratiopeptidase or Oral Dexamethasone in Reducing Postoperative Complications Following Impacted Lower Third Molar Surgery: A Prospective, Randomized, Double-Blind, Controlled Clinical Trial.

Authors:  Essam Ahmed Al-Moraissi; Elham Aziz Al-Zendani; Abeer Mohammed Al-Selwi
Journal:  Front Oral Health       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.